TuHURA Biosciences, Inc. (HURA)
NASDAQ: HURA · Real-Time Price · USD
2.030
-0.020 (-0.98%)
At close: Sep 15, 2026, 4:00 PM EDT
2.030
0.00 (0.00%)
After-hours: Sep 15, 2026, 4:10 PM EDT
TuHURA Biosciences Employees
TuHURA Biosciences had 22 employees as of December 31, 2025. The number of employees increased by 3 or 15.79% compared to the previous year.
Employees
22
Change (1Y)
3
Growth (1Y)
15.79%
Revenue / Employee
n/a
Profits / Employee
-$1,392,365
Market Cap
129.37M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 22 | 3 | 15.79% |
| Dec 31, 2024 | 19 | 18 | 1,800.00% |
| Dec 31, 2023 | 1 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Cellectis | 229 |
| LENZ Therapeutics | 152 |
| Inovio Pharmaceuticals | 112 |
| Caribou Biosciences | 97 |
| enGene Therapeutics | 82 |
| OnKure Therapeutics | 45 |
| Milestone Pharmaceuticals | 38 |
| Biomea Fusion | 37 |
HURA News
- 1 day ago - TuHURA Biosciences: FDA clears IND for TBS-2025 VISTA-inhibiting antibody - TheFly
- 1 day ago - TuHURA Biosciences Receives FDA "Study May Proceed" Notice and IND Clearance for the Evaluation of its TBS-2025 VISTA-Inhibiting Antibody in Molecularly Defined Subsets of AML and Other Blood-Related Cancers - PRNewsWire
- 7 days ago - TuHURA Biosciences to Present at the H.C. Wainwright 28th Annual Global Investment Conference - PRNewsWire
- 4 weeks ago - TuHURA Biosciences Transcript: AGM 2026 - Transcripts
- 4 weeks ago - TuHURA Biosciences Reports Second Quarter 2026 Financial Results and Provides a Corporate Update - PRNewsWire
- 4 weeks ago - TuHURA Biosciences Earnings release: Q2 2026 - Filings
- 4 weeks ago - TuHURA Biosciences Quarterly report: Q2 2026 - Filings
- 4 weeks ago - TuHURA Biosciences Transcript: Canaccord Genuity's 46th Annual Growth Conference - Transcripts